Unique ID issued by UMIN | UMIN000047953 |
---|---|
Receipt number | R000054670 |
Scientific Title | A prospective study investigating the efficacy and safety of traction-band-assisted endoscopic closure for mucosal defect after colorectal endoscopic submucosal dissection: A multi-center trial (TBEC Trial) |
Date of disclosure of the study information | 2022/06/05 |
Last modified on | 2025/06/09 03:20:24 |
A prospective study investigating the efficacy and safety of traction-band-assisted endoscopic closure for mucosal defect after colorectal endoscopic submucosal dissection: A multi-center trial (TBEC Trial)
TBEC Trial
A prospective study investigating the efficacy and safety of traction-band-assisted endoscopic closure for mucosal defect after colorectal endoscopic submucosal dissection: A multi-center trial (TBEC Trial)
TBEC Trial
Japan |
Colorectal neoplasms
Gastroenterology |
Malignancy
NO
To investigate the efficaty of traction band for endoscopic closure of mucosal defect after colorectal endoscopic submucosal dissection
Safety,Efficacy
Complete closure of mucosal defect
The number of traction device and clip required, closure time, ESD procedure time, en bloc resection, complete resection, curative resection, adverse events
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Traction-band-assisted endoscopic closure (TBEC) for mucosal defect after colorectal ESD
20 | years-old | <= |
99 | years-old | >= |
Male and Female
(1)Presence of colorectal neoplasms with 20-50mm in size diagnosed by endoscopy and capable of undergoing ESD as a local treatment
(2)Lesions diagnosed as colorectal adenomas or adenocarcinomas (cT1a)
(3)20 years old or more
(4)Performance Status: 0, 1, 2
(5)Informed consent is obtained
(1)Lesions spreading to the Bauhin bulb or appendix
(2)Lesions spreading to the diverticulum
(3)Lesions located at the lower rectum
(4)Currently undergoing dialysis
(5)Requiring continuous administration of heparin during the perioperative period.
(6)Patients taking steroids or immunosuppressive drugs
(7)Those with contraindications for endoscopy
(8)Patients judged to be inappropriate for the study by the attending physician in this trial
34
1st name | Yorinobu |
Middle name | |
Last name | Sumida |
Kitakyushu Municipal Medical Center
Department of Gastroenterology
802-8561
2-1-1, Bashaku, Kokura-kitaku, Kitakyushu
0935411831
y.raisin@gmail.com
1st name | Yorinobu |
Middle name | |
Last name | Sumida |
Kitakyushu Municipal Medical Center
Department of Gastroenterology
802-8561
2-1-1, Bashaku, Kokura-kitaku, Kitakyushu
0935411831
y.raisin@gmail.com
Kitakyushu Municipal Medical Center
Kyushu University
Self funding
IRB of Kitakyushu City Hospita Organization
1-35, Kofunabemachi, Kokurakita-ku, Kitakyushu City
093-533-5615
kcho-kenkyu01@kitakyu-cho.jp
NO
2022 | Year | 06 | Month | 05 | Day |
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2591-7104
Published
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2591-7104
34
A total of 34 patients with colorectal neoplasms measuring 20-50 mm scheduled for ESD were enrolled. TBEC was performed at each mucosal defect after ESD. TBEC yielded a 100% (95%CI 89.8%-100%) complete closure rate, with a median (interquartile range [IQR]) closure time of 14.5 (12.9) minutes. The median (IQR) number of clips used was 10 (3.3). One case of delayed bleeding and one of post-ESD coagulation syndrome (both 2.9% [95%CI 0.5%-14.9%]) occurred following TBEC.
2025 | Year | 06 | Month | 09 | Day |
A total of 80 patients underwent colorectal ESD from June 2022 to March 2023, of whom34were finally enrolled.
Moreover, the safety analysis, full analysis, and per-protocol set seach consisted of all 34 patients.
The median (IQR) tumor diameter was 29.0 (10.3) mm.
This multicenter prospective single-arm pilot study was conducted at three institutions from June 2022 to March 2023. A total of 34 patients with colorectal neoplasms measuring 20-50 mm scheduled for ESD were enrolled. TBEC was performed at each mucosal defect after ESD.
One case of delayed bleeding and one of post-ESD coagulation syndrome occurred following TBEC.
The primary outcome was the complete closure rate by TBEC. Secondary outcomes included the number of clips used, procedure time, and adverse events (AEs).
Main results already published
2022 | Year | 05 | Month | 31 | Day |
2022 | Year | 05 | Month | 31 | Day |
2022 | Year | 06 | Month | 06 | Day |
2024 | Year | 03 | Month | 31 | Day |
2024 | Year | 03 | Month | 31 | Day |
2024 | Year | 03 | Month | 31 | Day |
2022 | Year | 06 | Month | 05 | Day |
2025 | Year | 06 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054670